drugset / Trial / NCT06500234
Nutrition Impact on Immunotherapy of Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
This study investigates nutritional status and outcomes of immuntherapy in cancer patients.
Timeline
- Start
- 2024-06-01
- Primary completion
- 2025-05-31
- Completion
- 2027-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Megestrol Acetate | Other / unclassified | 160 mg | Oral |
| Subject | Olanzapine | Small molecule | 2.5 mg | Oral |